,50 Therapeutically inhibiting SARM1 may therefore be a putatively viable strategy for treating neurodegenerative diseases characterized by axon loss, such as amyotrophic lateral sclerosis.42 Here, SARM1 is linked to amyotrophic lateral sclerosis.